BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20922573)

  • 21. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants in CHEK1 gene are associated with the prognosis of thoracic esophageal squamous cell carcinoma patients treated with radical resection.
    Li J; Tang Y; Huang L; Yu QQ; Hu GY; Chen C; Zhang P; Yuan XL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):828-833. PubMed ID: 27924519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
    Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
    Yang PW; Huang YC; Hsieh CY; Hua KT; Huang YT; Chiang TH; Chen JS; Huang PM; Hsu HH; Kuo SW; Kuo ML; Lee JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S601-9. PubMed ID: 24770678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma.
    Yang PW; Huang PM; Yong LS; Chang YH; Wu CW; Hua KT; Hsieh MS; Lee JM
    Ann Surg Oncol; 2018 Aug; 25(8):2449-2456. PubMed ID: 29948421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
    Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.
    Plum PS; Hölscher AH; Pacheco Godoy K; Schmidt H; Berlth F; Chon SH; Alakus H; Bollschweiler E
    Surg Endosc; 2018 Sep; 32(9):3972-3980. PubMed ID: 29536160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
    Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
    Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
    Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
    Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.
    Talsma K; van Hagen P; Grotenhuis BA; Steyerberg EW; Tilanus HW; van Lanschot JJ; Wijnhoven BP
    Ann Surg Oncol; 2012 Jul; 19(7):2142-8. PubMed ID: 22395974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retrospective studies.
    Pan W; Sun Z; Xiang Y; Fang W
    Asia Pac J Clin Nutr; 2015; 24(3):480-8. PubMed ID: 26420190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study.
    Dura P; Salomon J; Te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
    BMC Gastroenterol; 2013 Jun; 13():97. PubMed ID: 23731957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
    Wu X; Gu J; Wu TT; Swisher SG; Liao Z; Correa AM; Liu J; Etzel CJ; Amos CI; Huang M; Chiang SS; Milas L; Hittelman WN; Ajani JA
    J Clin Oncol; 2006 Aug; 24(23):3789-98. PubMed ID: 16785472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.
    Yang PW; Hsieh MS; Huang YC; Hsieh CY; Chiang TH; Lee JM
    PLoS One; 2014; 9(6):e100326. PubMed ID: 24945674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.